EssilorLuxottica Strengthens Global Eye-Health Leadership Through New Role in Collaborative Community of Ophthalmic Innovation

EssilorLuxottica Strengthens Global Eye-Health Leadership Through New Role in Collaborative Community of Ophthalmic Innovation

(IN BRIEF) EssilorLuxottica has joined the Collaborative Community of Ophthalmic Innovation (CCOI), reinforcing its commitment to advancing patient-centered eye-health solutions through global scientific collaboration. By participating in this international network of clinicians, researchers, regulators, industry, and patient groups, the company will apply its strengths in optical engineering, digital health, and imaging—supported by Heidelberg Engineering’s long-established expertise—to accelerate the transition of scientific insights into clinical practice. As a top-level “Vision Architect” member, EssilorLuxottica will help guide consensus-based global standards and contribute to key CCOI workstreams involving myopia, oculomics, AI, glaucoma, and age-related macular degeneration. The partnership reflects the Group’s strategy of driving evidence-based innovation that improves the detection, management, and prevention of eye diseases while supporting the broader evolution of ophthalmic care worldwide.

(PRESS RELEASE) PARIS, 13-Nov-2025 — /EuropaWire/ — EssilorLuxottica has strengthened its role in advancing global eye-health innovation by joining the Collaborative Community of Ophthalmic Innovation (CCOI), an international forum that unites patients, clinicians, researchers, regulators, and industry leaders to accelerate scientific progress into practical ophthalmic solutions. The initiative aims to harness collective expertise to unlock the full potential of the eye as a powerful source of medical insight, ultimately driving new diagnostic and therapeutic breakthroughs with benefits that extend far beyond ophthalmology.

By becoming part of the CCOI, EssilorLuxottica underscores its long-standing commitment to innovation that centres on patient needs, ranging from advanced diagnostic tools and digital technologies to data-driven solutions that improve the understanding and management of eye diseases. Through rigorous scientific collaboration and a focus on consensus-building across stakeholders, the Group will integrate its strengths in optical engineering, digital health, and global operational scale to help accelerate the translation of emerging research into real-world patient benefit.

“We are joining this Community at the highest tier of industry participation because we believe collaboration is essential to progress in ophthalmic science,” said Dr. Norbert Gorny, Chief Scientific Officer at EssilorLuxottica. “Combining our capabilities with the Community’s collective expertise will help speed the transition from scientific discovery to clinical impact. We are also pleased to bring the expertise of Heidelberg Engineering, whose longstanding leadership in medical imaging and data science will contribute meaningfully to the next wave of evidence-based ophthalmic innovation.”

Dr. Malvina Eydelman, CEO of the Collaborative Community of Ophthalmic Innovation, welcomed the Group’s involvement, noting: “We are delighted to have EssilorLuxottica join as a Vision Architect. Their leadership will influence global scientific frameworks, particularly through their contributions to CCOI’s Endpoints Consensus Workshops and global standards initiatives. Their participation will help shape a unified, patient-focused foundation for future ophthalmic advancements.”

Maintaining its open and collaborative philosophy, EssilorLuxottica will contribute to several of the CCOI’s strategic workstreams, including those focused on myopia, oculomics, artificial intelligence, glaucoma, and age-related macular degeneration. Through these efforts, the company aims to apply its technological and scientific capabilities to strengthen global eye-health systems and support transformative advances in ophthalmology.

Media Contacts:

Giorgio Iannella
Head of Investor Relations
ir@essilorluxottica.com

Marco Catalani
Head of Corporate Communications
media@essilorluxottica.com

About EssilorLuxottica
EssilorLuxottica is a global leader in the design, manufacture and distribution of advanced vision care products, eyewear and med-tech solutions. Its Mission is to help people around the world to see more and be more by addressing their evolving vision needs, personal style aspirations and desire to feel more connected to the world around them. EssilorLuxottica is home to the most innovative lens technologies, including Varilux, Stellest and Transitions, iconic brands such as Ray-Ban, Oakley and Supreme, the most desired luxury licensed brands and world-class retailers including Sunglass Hut, LensCrafters, Vision Express and Apollo. Backed by robust R&D investments, distinctive capabilities and a top-quality asset portfolio, the Company drives innovation across categories, from cutting-edge medical instruments and solutions for eye health to category-defining smart glasses, all of which push the boundaries of the industry and reimagine the eyes as a gateway to new possibilities. With
over 200,000 employees across 150 countries, 600 operations facilities, serving 300,000 eye care professionals and operating 18,000 stores, the Group generated consolidated revenue of Euro 26.5 billion in 2024. Its OneSight
EssilorLuxottica Foundation has given access to sustainable vision care to nearly 1 billion people in underserved communities. EssilorLuxottica trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC
40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESLX.PA; Bloomberg: EL:FP. www.essilorluxottica.com

SOURCE: EssilorLuxottica